Omnicare Bolsters Case Against Ex-Merck VP, Investors Say
Shareholders accusing Merck & Co. Inc.'s former vice president of lying about the study results on Vioxx's heart attack link told a New Jersey federal court Wednesday that the U.S. Supreme...To view the full article, register now.
Already a subscriber? Click here to view full article